Fletcher Mark

Generex Biotechnology Corp.

EVP General Counsel &Secretary

Avg. Two Year Performance

(50%) Avg. Purchase Return (22%) Compound

63% Avg. Sale Return 28% Compound

Holdings: 15.82M shares

Last Three Months: 24-Aug-24 -- 23-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drug Delivery

Drugs

Two Year Chart

24-Nov-22 -- 23-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions